Nasdaq · Healthcare
BillionToOne, Inc. (BLLN)
As-reported financials and recent SEC filings for BillionToOne, Inc., latest fiscal period FY2025. Every figure is pulled straight from the company’s EDGAR filings — no estimates.
Snapshot
Revenue
$305.1M
Net income
$7.5M
Net margin
2.4%
Diluted EPS
$0.14
ROE
1.6%
P/E (TTM)
218.8×
Market cap
$5.44B
Debt / equity
0.1×
Income statement (as reported)
| Line | FY2025 | FY2025 | FY2025 |
|---|---|---|---|
| Revenue | $305.1M | $152.6M | $71.7M |
| Gross profit | $208.5M | $80.9M | $17.3M |
| Operating income | $16.0M | $-47.1M | $-69.5M |
| Net income | $7.5M | $-41.6M | $-82.7M |
| Diluted EPS | $0.14 | $-2.06 | $-4.22 |
Source: company XBRL financial statements on SEC EDGAR.
Recent SEC filings
42026-06-26
View on EDGAR →1442026-06-24
View on EDGAR →42026-06-17
View on EDGAR →42026-06-17
View on EDGAR →8-K2026-06-16
View on EDGAR →1442026-06-15
View on EDGAR →1442026-06-15
View on EDGAR →1442026-06-15
View on EDGAR →Go deeper on BLLN
Search BillionToOne, Inc.’s filings with cited answers, compare it against peers, build an operating model, and track it in your portfolio — all in one place.
Start freeData sourced from SEC EDGAR (public domain). Figures are as-reported and may be unaudited or restated; verify against the source filing before relying on them. Informational only — not investment advice.